PUBLIC CONTRACT · 2018
Aquisição de Belimumab 400 mg Pó Conc. Sol. Inj. Fr. IV
- Contract value
- €5,664.62
- Signed on
- 1 August 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4752828PUBLISHED SUBJECT
Aquisição de Belimumab 400 mg Pó Conc. Sol. Inj. Fr. IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Glaxosmithkline, Lda. · Tax ID 500139962
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €5,664.62
- Procedure base price
- €5,664.62
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 August 2018
- Award date
- 1 August 2018
- Signing date
- 1 August 2018
- Performance period
- 150 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3577299
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.